Offers from La Merie Publishing

/

Offers

Offers

PD-1 x VEGF and PD-L1 x VEGF bispecific antibodies: a business, pipeline and competitor analysis from an industry perspective

€ 1800.00
Claudin 18.2-Targeted Immunotherapy: a landscape analysis of stakeholders, drug modalities, pipeline and business opportunities from an industry perspective

€ 1720.00
Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

€ 1800.00
2FOR1 Report Package: Vectorized Antibody and Prodrug Antibody & Cytokine landscape analysis report package with 50% discount

€ 2200.00
Report Package: “Drug the Undruggable” Technologies

€ 4125.00
Report Package: Bispecific Antibodies

€ 2500.00
Report Package: TCR-Based Antibody and T-Cell Immunotherapy

€ 2670.00
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends

€ 2000.00